Vaccine-maker’s Ottawa R&D efforts get boost thanks to millions in fresh funding
VBI Vaccines will immediately have access to up to $50 million (all terms U.S.) in cash, consisting of $30 million in refinanced funding as well
Skip to content
VBI Vaccines
Biotech firm with major Ottawa footprint taps into US$12M in new financing
VBI Vaccines is working on a locally developed COVID-19 vaccine as well as jabs that target diseases such as cancer and hepatitis B.
Biotech firm gets US$33M boost for Ottawa-developed COVID-19 vaccine targeting new variants
Massachusetts-based VBI Vaccines began clinical trials at the Ottawa Hospital this week on the first version of its product.
Ottawa biotech lab gets $56M shot in the arm for COVID vaccine research
Variation Biotechnologies is working with the National Research Council to create a vaccine that would target the novel coronavirus as well as other deadly viruses.
Ottawa research lab partners with NRC to develop COVID vaccine
An Ottawa-born pharmaceutical company is teaming up with the National Research Council in a bid to develop a vaccine that will target COVID-19 as well
Get our email newsletters
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.
The Latest
Video
OBJ360
Sponsored
Sponsored
The Ottawa Hospital Foundation’s Campaign to Create Tomorrow
The $500-million fundraising campaign is the largest in our city’s history. It will reshape the future of healthcare in Ottawa and beyond.
EXPERT BLOGS
What about the First Home Savings Account?
Joelle Hall
10 essential considerations when selling your business
Gobel, Sampson & Associates Private Wealth Management
